Matthieu Le Gallo

6PUBLICATIONS
19CO-AUTHORS
Ecological impacts of climate change and ecological adaptationMolecular targetsCybercrimeCancer diagnosisPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 16, 2026
Ubiquitin and ubiquitin-like modifications in the endoplasmic reticulum stress response.

|Feb 22, 2024
IRE1 RNase controls CD95-mediated cell death.

Diana Pelizzari-Raymundo, Victoria Maltret, Manon Nivet

|Jan 25, 2023
Metalloprotease-mediated cleavage of CD95 ligand.

Vesna Risso, Mélissa Thomas, Blandine Guével

|Mar 18, 2022
Therapeutic approaches targeting CD95L/CD95 signaling in cancer and autoimmune diseases.

Vesna Risso, Elodie Lafont, Matthieu Le Gallo

|Oct 27, 2021
An EMT-primary cilium-GLIS2 signaling axis regulates mammogenesis and claudin-low breast tumorigenesis.

Molly M Wilson, Céline Callens, Matthieu Le Gallo

|Sep 21, 2019
Serum CD95L Level Correlates with Tumor Immune Infiltration and Is a Positive Prognostic Marker for Advanced High-Grade Serous Ovarian Cancer.

Thibault De La Motte Rouge, Julien Corné, Aurélie Cauchois

Pageof 1

Frequent Collaborators

4 joint publications

Elodie Lafont

2 joint publications

Tony Avril

2 joint publications

Sophie Martin

2 joint publications

Éric Chevet